J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. Coebergh et al., Cancer incidence and mortality patterns in Europe: Estimates for 40, 2012.

, European Journal of Cancer. avr, vol.49, issue.6, pp.1374-403, 2013.

T. Delozier, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, déc, vol.39, issue.8, pp.71-79, 2010.

M. Hammond, D. F. Hayes, M. Dowsett, D. C. Allred, K. L. Hagerty et al.,

, College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, JCO. juin, vol.28, issue.16, pp.2784-95, 2010.

S. P. Li, A. R. Padhani, N. J. Taylor, M. J. Beresford, A. Stirling et al., Vascular characterisation of triple negative breast carcinomas using dynamic MRI, Eur Radiol. juill, vol.21, issue.7, pp.1364-73, 2011.

W. D. Foulkes and J. S. Reis-filho, Triple-Negative Breast Cancer, The New England Journal of Medicine, p.11, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02463255

J. Billar, A. C. Dueck, C. Stucky, R. J. Gray, N. Wasif et al., Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes, Ann Surg Oncol, vol.17, issue.S3, pp.384-90, 2010.

N. C. Turner and J. S. Reis-filho, Tackling the Diversity of Triple-Negative Breast Cancer

, Clinical Cancer Research. 1 déc, vol.19, issue.23, pp.6380-6388, 2013.

R. Dent, M. Trudeau, K. I. Pritchard, W. M. Hanna, H. K. Kahn et al., Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence, Clinical Cancer Research. 1 août, vol.13, issue.15, pp.4429-4463, 2007.

J. Chen, G. Agrawal, B. Feig, H. Baek, P. M. Carpenter et al., Triplenegative breast cancer: MRI features in 29 patients, Annals of Oncology. 1 déc, vol.18, issue.12, pp.2042-2045, 2007.

K. R. Bauer, M. Brown, R. D. Cress, C. A. Parise, and V. Caggiano, Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry, Cancer. 1 mai, vol.109, issue.9, pp.1721-1729, 2007.

G. J. Whitman, C. T. Albarracin, and A. M. Gonzalez-angulo, Triple-Negative Breast Cancer: What the Radiologist Needs to Know, Seminars in Roentgenology. janv, vol.46, issue.1, pp.26-39, 2011.

Y. Kojima and H. Tsunoda, Mammography and ultrasound features of triple-negative breast cancer, Breast Cancer. juill, 2011.

B. E. Dogan, A. M. Gonzalez-angulo, M. Gilcrease, M. J. Dryden, and W. T. Yang, Multimodality Imaging of Triple Receptor-Negative Tumors With Mammography, Ultrasound, and MRI

, American Journal of Roentgenology. avr, vol.194, issue.4, pp.1160-1166, 2010.

W. Yang, M. Dryden, K. Broglio, M. Gilcrease, S. Dawood et al.,

, Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women, Breast Cancer Res Treat, vol.111, issue.3, pp.405-415, 2008.

E. S. Ko, B. H. Lee, H. Kim, W. Noh, M. S. Kim et al., Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer, Eur Radiol. mai, vol.20, issue.5, pp.19-30, 2010.

M. Boisserie-lacroix, M. Grogan, G. Debled, M. Ferron, S. Asad-syed et al., Radiological features of triple-negative breast cancers (73 cases). Diagnostic and Interventional Imaging, mars, vol.93, issue.3, pp.183-90, 2012.

T. Uematsu, M. Kasami, and S. Yuen, Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings, Radiology. mars, vol.250, issue.3, pp.638-685, 2009.

J. Chen, H. Baek, O. Nalcioglu, and M. Su, Estrogen receptor and breast MR imaging features: A correlation study, J Magn Reson Imaging. avr, vol.27, issue.4, pp.825-858, 2008.

A. Teifke, O. Behr, M. Schmidt, A. Victor, T. W. Vomweg et al., Dynamic MR Imaging of Breast Lesions: Correlation with Microvessel Distribution Pattern and Histologic Characteristics of Prognosis, Radiology. mai, vol.239, issue.2, pp.351-60, 2006.

R. E. Jimenez, T. Wallis, and D. W. Visscher, Centrally Necrotizing Carcinomas of the Breast

, A Distinct Histologic Subtype With Aggressive Clinical Behavior, The American Journal of Surgical Pathology. mars, vol.25, issue.3, pp.331-338, 2001.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai et al., Response to

, Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer, JCO. 10 mars, vol.26, issue.8, pp.1275-81, 2008.

G. Von-minckwitz, M. Untch, E. Nüesch, S. Loibl, M. Kaufmann et al., Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials, Breast Cancer Res Treat. janv, vol.125, issue.1, pp.145-56, 2011.

G. Von-minckwitz, M. Untch, J. Blohmer, S. D. Costa, H. Eidtmann et al.,

, Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, JCO. 20 mai, vol.30, issue.15, pp.1796-804, 2012.

J. Ferlay, M. Colombet, and I. Soerjomataram, Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int J Cancer, 2018.

J. Billar, A. C. Dueck, and C. Stucky, Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes, Ann Surg Oncol, vol.17, pp.384-390, 2010.

W. D. Foulkes and J. S. Reis-filho, Triple-Negative Breast Cancer, N Engl J Med, p.11, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02463255

G. Von-minckwitz, J. U. Blohmer, and S. D. Costa, Response-Guided Neoadjuvant Chemotherapy for Breast Cancer, J Clin Oncol, vol.31, pp.3623-3630, 2013.

W. J. Gradishar, B. O. Anderson, and R. Balassanian, Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw, vol.16, pp.310-320, 2018.

M. Derks and C. Van-de-velde, Neoadjuvant chemotherapy in breast cancer: more than just downsizing, Lancet Oncol, vol.19, pp.2-3, 2018.

X. Kong, M. S. Moran, N. Zhang, B. Haffty, and Q. Yang, Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients, Eur J Cancer, vol.47, pp.2084-2090, 2011.

C. Liedtke, C. Mazouni, and K. R. Hess, Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer, J Clin Oncol, vol.26, pp.1275-1281, 2008.

H. Earl, E. Provenzano, and J. Abraham, Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes -what does it all mean, BMC Med, vol.13, p.234, 2015.

N. Houssami, P. Macaskill, G. Von-minckwitz, M. L. Marinovich, and E. Mamounas, Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy, Eur J Cancer, vol.48, pp.3342-3354, 2012.

R. M. Mann and C. Balleyguier, with language review by Europa Donna-The European Breast Cancer Coalition, Breast MRI: EUSOBI recommendations for women's information, vol.25, pp.3669-3678, 2015.

P. Lambin, E. Rios-velazquez, and R. Leijenaar, Radiomics: Extracting more information from medical images using advanced feature analysis, Eur J Cancer, vol.48, pp.441-446, 2012.

P. Lambin, R. Leijenaar, and T. M. Deist, Radiomics: the bridge between medical imaging and personalized medicine, Nat Rev Clin Oncol, vol.14, pp.749-762, 2017.

R. J. Gillies, P. E. Kinahan, and H. Hricak, Radiomics: Images Are More than Pictures, They Are Data, Radiology, vol.278, pp.563-577, 2016.

Z. Liu, S. Wang, and D. Dong, The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges, Theranostics, vol.9, pp.1303-1322, 2019.

E. J. Limkin, R. Sun, and L. Dercle, Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology, Ann Oncol, vol.28, pp.1191-1206, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01648559

S. C. Agner, M. A. Rosen, and S. Englander, Computerized Image Analysis for Identifying Triple-Negative Breast Cancers and Differentiating Them from Other Molecular Subtypes of Breast Cancer on Dynamic Contrast-enhanced MR Images: A Feasibility Study, Radiology, vol.272, pp.91-99, 2014.

L. Alic, W. J. Niessen, and J. F. Veenland, Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review, PLoS ONE, vol.9, p.110300, 2014.

Y. Huang, C. Liang, and L. He, Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer, J Clin Oncol, vol.34, pp.2157-2164, 2016.

J. Guo, Z. Liu, and C. Shen, MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation, Eur Radiol, vol.28, pp.3872-3881, 2018.

H. Aerts, E. R. Velazquez, and R. Leijenaar, Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat Commun, vol.5, p.4006, 2014.

Z. Liu, Y. Wang, and X. Liu, Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas, NeuroImage Clin, vol.19, pp.271-278, 2018.

S. Yip and H. Aerts, Applications and limitations of radiomics, Phys Med Biol, vol.61, pp.150-166, 2016.

Y. Zhu, H. Li, and W. Guo, Deciphering Genomic Underpinnings of Quantitative MRIbased Radiomic Phenotypes of Invasive Breast Carcinoma, Sci Rep, vol.5, p.17787, 2015.

W. Guo, H. Li, and Y. Zhu, Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data, J Med Imaging, vol.2, p.41007, 2015.

E. S. Burnside, K. Drukker, and H. Li, Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage: Breast MRI Phenotypes Predict Stage, Cancer, vol.122, pp.748-757, 2016.

J. Kim, E. S. Ko, and Y. Lim, Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes, Radiology, vol.282, pp.665-675, 2017.

J. Wu, G. Gong, Y. Cui, and R. Li, Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy: Intratumor Partitioning of Breast Cancer, J Magn Reson Imaging, vol.44, pp.1107-1115, 2016.

Z. Liu, Z. Li, and J. Qu, Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study, Clin Cancer Res, vol.25, pp.3538-3547, 2019.

. Chamming's-f, Y. Ueno, and R. Ferré, Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy, Radiology, vol.286, pp.412-420, 2018.

M. Fan, G. Wu, H. Cheng, J. Zhang, G. Shao et al., Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients, Eur J Radiol, vol.94, pp.140-147, 2017.

J. Wang, F. Kato, and N. Oyama-manabe, Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study, PLOS ONE, vol.10, p.143308, 2015.

J. J. Weber, M. S. Jochelson, and A. Eaton, MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer, J Am Coll Surg, vol.225, pp.740-746, 2017.

N. M. Braman, M. Etesami, and P. Prasanna, Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI, Breast Cancer Res, vol.19, p.57, 2017.

D. F. Quail and J. A. Joyce, Microenvironmental regulation of tumor progression and metastasis

, Nat Med, vol.19, pp.1423-1437, 2013.

T. Suk and J. Flusser, Combined blur and affine moment invariants and their use in pattern recognition, Pattern Recognit, vol.36, pp.2895-2907, 2003.

M. Hu, Visual pattern recognition by moment invariants, IEEE Trans Inf Theory, vol.8, pp.179-187, 1962.

A. Tahmasbi, F. Saki, and S. B. Shokouhi, Classification of benign and malignant masses based on Zernike moments, Comput Biol Med, vol.41, pp.726-735, 2011.

F. Saki, A. Tahmasbi, H. Soltanian-zadeh, and S. B. Shokouhi, Fast opposite weight learning rules with application in breast cancer diagnosis, Comput Biol Med, vol.43, pp.32-41, 2013.

K. P. Mcgee, A. Manduca, J. P. Felmlee, S. J. Riederer, and R. L. Ehman, Image metric-based correction (autocorrection) of motion effects: analysis of image metrics, J Magn Reson Imaging JMRI, vol.11, pp.174-181, 2000.

I. Kononenko, E. Simec, and M. Robnik-sikonja, Overcoming the myopia of inductive learning algorithms with RELIEFF, p.17

H. He, Y. Bai, E. A. Garcia, and S. Li, ADASYN: Adaptive synthetic sampling approach for imbalanced learning, IEEE Int Jt Conf Neural Netw IEEE World Congr Comput Intell, pp.1322-1328, 2008.

H. He and E. A. Garcia, Learning from Imbalanced Data, IEEE Trans Knowl Data Eng, vol.21, pp.1263-1284, 2009.

. Chamming's-f, Y. Ueno, and R. Ferré, Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy, Radiology, vol.286, pp.412-420, 2018.

J. Yan, J. L. Chu-shern, and H. Y. Loi, Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET, J Nucl Med, vol.56, pp.1667-1673, 2015.

J. Fortin, D. Parker, and B. Tunç, Harmonization of multi-site diffusion tensor imaging data, NeuroImage, vol.161, pp.149-170, 2017.

S. Reuzé, F. Orlhac, and C. Chargari, Prediction of cervical cancer recurrence using textural features extracted from 18 F-FDG PET images acquired with different scanners, Oncotarget, 2017.

C. K. Kuhl, S. Schrading, K. Strobel, H. H. Schild, R. Hilgers et al., Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection-A Novel Approach to Breast Cancer Screening With MRI, J Clin Oncol, vol.32, pp.2304-2310, 2014.

M. Moschetta, M. Telegrafo, L. Rella, S. Ianora, A. A. Angelelli et al., Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions, Clin Breast Cancer, vol.16, pp.207-211, 2016.

G. Oldrini, B. Fedida, and J. Poujol, Abbreviated breast magnetic resonance protocol: Value of high-resolution temporal dynamic sequence to improve lesion characterization, Eur J Radiol, vol.95, pp.177-185, 2017.

J. F. De-los-santos, A. Cantor, K. D. Amos, A. Forero, M. Golshan et al.,

, Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017, Cancer. 15 mai, vol.119, issue.10, pp.1776-83, 2013.

S. Bahri, J. Chen, R. S. Mehta, P. M. Carpenter, K. Nie et al., Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and Without Bevacizumab, Ann Surg Oncol. juin, vol.16, issue.6, pp.1619-1647, 2009.